AU6846700A - Benzoxazine derivatives and their therapeutic use - Google Patents

Benzoxazine derivatives and their therapeutic use

Info

Publication number
AU6846700A
AU6846700A AU68467/00A AU6846700A AU6846700A AU 6846700 A AU6846700 A AU 6846700A AU 68467/00 A AU68467/00 A AU 68467/00A AU 6846700 A AU6846700 A AU 6846700A AU 6846700 A AU6846700 A AU 6846700A
Authority
AU
Australia
Prior art keywords
therapeutic use
benzoxazine derivatives
benzoxazine
derivatives
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68467/00A
Inventor
Daniel Achard
Patrick Jimonet
Patrick Mailliet
Jean-Francois Sabuco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU6846700A publication Critical patent/AU6846700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU68467/00A 1999-07-30 2000-07-28 Benzoxazine derivatives and their therapeutic use Abandoned AU6846700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9909894 1999-07-30
FR9909894A FR2796943A1 (en) 1999-07-30 1999-07-30 BENZOXAZINN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE IN THERAPEUTICS
PCT/FR2000/002190 WO2001009127A1 (en) 1999-07-30 2000-07-28 Benzoxazine derivatives and their therapeutic use

Publications (1)

Publication Number Publication Date
AU6846700A true AU6846700A (en) 2001-02-19

Family

ID=9548696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68467/00A Abandoned AU6846700A (en) 1999-07-30 2000-07-28 Benzoxazine derivatives and their therapeutic use

Country Status (3)

Country Link
AU (1) AU6846700A (en)
FR (1) FR2796943A1 (en)
WO (1) WO2001009127A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2007004161A0 (en) 2005-04-28 2007-10-31 Pfizer Ltd Amino acid derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318965A (en) * 1990-08-24 1994-06-07 Abbott Laboratories Quinobenzoxazine, antineoplastic agents
CA2118985A1 (en) * 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
FR2729390A1 (en) * 1995-01-18 1996-07-19 Rhone Poulenc Rorer Sa NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2730492B1 (en) * 1995-02-09 1997-03-14 Rhone Poulenc Rorer Sa NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL123568A (en) * 1995-12-08 2001-08-08 Janssen Pharmaceutica Nv Farnesyl protein transferase inhibiting (imidazole-5-yl) methyl-2-quinolinone derivatives, their preparation, pharmaceutical compositions containing them and their preparation, and medicaments comprising them
US6011029A (en) * 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
EP1027042A4 (en) * 1997-09-29 2004-08-18 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
ES2193590T3 (en) * 1997-11-28 2003-11-01 Lg Chemical Ltd IMIDAZOL DERIVATIVES THAT HAVE INHIBITORY ACTIVITY AGAINST FARNESIL TRANSFERASA AND PROCEDURE FOR THE PREPARATION OF THE SAME.

Also Published As

Publication number Publication date
WO2001009127A1 (en) 2001-02-08
FR2796943A1 (en) 2001-02-02

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU715620C (en) Therapeutic methods and uses
ZA989556B (en) Benzoxazine derivatives their preparation and their therapeutic application
AU1164601A (en) Therapeutic use and formulation
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU2001289758A1 (en) Novel indole derivatives and their use as medicaments
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
AU7271600A (en) Quinazolinone and azaquinazolinone derivatives
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU6846500A (en) Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU1887301A (en) Heterocycle derivatives and drugs
AU2669201A (en) Taccalonolides and their use
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU3971800A (en) 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
AU6846700A (en) Benzoxazine derivatives and their therapeutic use
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase